Sweden's Karo Pharma is acquiring Sylphar Group and its dietary supplement and beauty brands sold around Europe, primarily online.

J&J provided color on plans for standalone consumer health business during a business overview with analysts. Multiple separation pathways are being considered.

The latest European consumer healthcare business news: Belgium's Ceres Pharma expands its portfolio with GlobiFer; and PharmaSGP achieves its best ever quarter thanks to the recovery of the OTC market.

Filling in the blanks for which ingredients qualify for definition of hemp could be as difficult and complicated as the question of lawful use, says food and drug attorneys. A DEA rule from legislation de-scheduling hemp left room for confusion on which substances qualify. 

On same day USP published report on delta-8 THC, former FDA executive who led a marijuana policy working group while there advised that banishing the ingredient won’t come any easier than controlling the use of hemp ingredients in non-drug products subject to the agency’s regulatory oversight.

Prestige hasn’t totally escaped supply chain disruptions caused by shutdowns during the pandemic but it’s relieved to report a smaller impact than most consumer-packaged goods marketers. Slower cough/cold OTC sales also don’t slow its results.

The latest European consumer healthcare business news: Belgium's Ceres Pharma expands its portfolio with GlobiFer; and PharmaSGP achieves its best ever quarter thanks to the recovery of the OTC market.

Product launches by Power Life Nutrition, PlantFuel Life, Cymbiotik and JSHealth; third-quarter sales up for ChromaDex and Mannatech, slip for MusclePharm and USANA.

Japan's Taisho reported higher sales in the six months ended 30 September as the continued recovery of the domestic OTC market offset a weaker performance overseas.

Procter & Gamble and Amazon are among nine companies FTC ordered to provide detailed information to help the agency identify causes behind ongoing supply chain disruptions. Chairwoman Khan says the information should “shed light on market conditions and business practices that may have worsened these disruptions.”

Xlear founder Nate Jones says FTC doesn’t argue that results and other information in research linked in social media posts, its website and a press release are false, but wants to prohibit providing information to consumers on research about preventing and treating COVID-19.

Three warnings during inspections, a warning letter and meeting with FDA officials didn’t stop Grandma’s Herbs from using drug claims. FTC reimburses consumers who bought three supplements deceptively marketed as treatments for pain and other health conditions related to aging.